SULLIVAN LOUIS W (CIK 1193522) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-12-23). Recent activity: Buy UTHR (3,230 shares), Buy UTHR (2,720 shares), Sell UTHR (1,087 shares), Sell UTHR (4,863 shares), Buy UTHR (590 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 3,230 | $594,255 |
| 2025-12-23 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 2,720 | $625,083 |
| 2025-12-23 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 1,087 | $555,696 |
| 2025-12-23 | UNITED THERAPEUTICS Corp (UTHR) | Director | Sell | 4,863 | $2.5M |
| 2025-07-28 | UNITED THERAPEUTICS Corp (UTHR) | Director | Buy | 590 | $0 |
| 2025-05-02 | Emergent BioSolutions Inc. (EBS) | Director | Buy | 34,403 | $0 |
Source: SEC Form 4 filings · as of 2025-12-23